These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16933372)

  • 1. FDA clears HIV drug for patients with resistant virus.
    AIDS Read; 2006 Aug; 16(8):392. PubMed ID: 16933372
    [No Abstract]   [Full Text] [Related]  

  • 2. Lower dose of ritonavir approved for use with fosamprenavir.
    Sax PE
    AIDS Clin Care; 2007 Dec; 19(12):106. PubMed ID: 18399004
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA approves new dosing for amprenavir and ritonavir combination.
    AIDS Treat News; 2002 Mar; (378):6-7. PubMed ID: 11965920
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA notifications. Potential serious effect of combination saquinavir-ritonavir.
    AIDS Alert; 2010 Apr; 25(4):45-6. PubMed ID: 20564774
    [No Abstract]   [Full Text] [Related]  

  • 5. Darunavir now approved for use in treatment-naive patients.
    Sax PE
    AIDS Clin Care; 2008 Dec; 20(12):102. PubMed ID: 19271337
    [No Abstract]   [Full Text] [Related]  

  • 6. New HIV treatment.
    FDA Consum; 2006; 40(5):7. PubMed ID: 17326304
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA notifications. FDA approves NDA for Lexiva.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960
    [No Abstract]   [Full Text] [Related]  

  • 8. Amping amprenavir with ritonavir.
    TreatmentUpdate; 2001; 12(12):10. PubMed ID: 11570075
    [No Abstract]   [Full Text] [Related]  

  • 9. TMC114 approved for resistant patients.
    AIDS Patient Care STDS; 2006 Oct; 20(10):731. PubMed ID: 17052143
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. FDA OKs new pediatric dosing for darunavir.
    AIDS Alert; 2009 Feb; 24(2):22-4. PubMed ID: 19222149
    [No Abstract]   [Full Text] [Related]  

  • 11. Kaletra OK'd by FDA.
    James JS
    Posit Living; 2000 Nov; 9(9):8, 13. PubMed ID: 12154764
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA approves darunavir.
    AIDS Patient Care STDS; 2008 Dec; 22(12):1021-2. PubMed ID: 19097261
    [No Abstract]   [Full Text] [Related]  

  • 13. New Norvir soft-gel capsule formulation approved by FDA.
    Gaylord G
    Posit Living; 1999 Aug; 8(7):11. PubMed ID: 12492076
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug interactions. Amprenavir with low-dose ritonavir.
    TreatmentUpdate; 2006; 18(3):9-10. PubMed ID: 17211921
    [No Abstract]   [Full Text] [Related]  

  • 15. Agenerase approved by FDA.
    Gaylord G
    Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
    [No Abstract]   [Full Text] [Related]  

  • 16. Darunavir: promising initial results.
    MacArthur RD
    Lancet; 2007 Apr; 369(9568):1143-4. PubMed ID: 17416241
    [No Abstract]   [Full Text] [Related]  

  • 17. 48-week study results show DRV's staying power.
    Bernard EJ
    IAPAC Mon; 2007 Jan; 13(1):10-1. PubMed ID: 17523243
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA notifications. HIV-1 adult treatment guidelines are updated.
    AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16795141
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA notifications. Generic lopinavir/ritonavir approved by FDA.
    AIDS Alert; 2009 May; 24(5):59. PubMed ID: 19452652
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA approval: darunavir.
    Sax PE
    AIDS Clin Care; 2006 Aug; 18(8):71. PubMed ID: 16906668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.